Department of Internal Medicine, School of Medicine, Keio University, Shinjujku-ku, Tokyo 160-8582, Japan.
Endocrinology. 2011 Jun;152(6):2266-77. doi: 10.1210/en.2010-1232. Epub 2011 Apr 5.
Steroidogenic factor-1 (SF-1) is a nuclear orphan receptor, which is essential for adrenal development and regulation of steroidogenic enzyme expression. SF-1 is posttranslationally modified by small ubiquitin-related modifier-1 (SUMO-1), thus mostly resulting in attenuation of transcription. We investigated the role of sumoylation enzymes, Ubc9 and protein inhibitors of activated STAT1 (PIAS1), in SF-1-mediated transcription of steroidogenic enzyme genes in the adrenal cortex. Coimmunoprecipitation assays showed that both Ubc9 and PIAS1 interacted with SF-1. Transient transfection assays in adrenocortical H295R cells showed Ubc9 and PIAS1 potentiated SF-1-mediated transactivation of reporter constructs containing human CYP17, CYP11A1, and CYP11B1 but not CYP11B2 promoters. Reduction of endogenous Ubc9 and PIAS1 by introducing corresponding small interfering RNA significantly reduced endogenous CYP17, CYP11A1, and CYP11B1 mRNA levels, indicating that they normally function as coactivators of SF-1. Wild type and sumoylation-inactive mutants of Ubc9 and PIAS1 can similarly enhance the SF-1-mediated transactivation of the CYP17 gene, indicating that the coactivation potency of Ubc9 and PIAS1 is independent of sumoylation activity. Chromatin immunoprecipitation assays demonstrated that SF-1, Ubc9, and PIAS1 were recruited to an endogenous CYP17 gene promoter in the context of chromatin in vivo. Immunohistochemistry and Western blotting showed that SF-1, Ubc9, and PIAS1 were expressed in the nuclei of the human adrenal cortex. In cortisol-producing adenomas, the expression pattern of SF-1 and Ubc9 were markedly increased, whereas that of PIAS1 was decreased compared with adjacent normal adrenals. These results showed the physiological roles of Ubc9 and PIAS1 as SF-1 coactivators beyond sumoylation enzymes in adrenocortical steroidogenesis and suggested their possible pathophysiological roles in human cortisol-producing adenomas.
类固醇生成因子 1(SF-1)是一种核孤儿受体,对于肾上腺发育和类固醇生成酶表达的调节至关重要。SF-1 可被小泛素相关修饰物-1(SUMO-1)进行翻译后修饰,从而主要导致转录衰减。我们研究了 SUMO 酶 Ubc9 和激活 STAT1 的蛋白抑制剂 1(PIAS1)在 SF-1 介导的肾上腺皮质类固醇生成酶基因转录中的作用。免疫共沉淀实验表明,Ubc9 和 PIAS1 均与 SF-1 相互作用。在肾上腺皮质 H295R 细胞中的瞬时转染实验表明,Ubc9 和 PIAS1 增强了含有人 CYP17、CYP11A1 和 CYP11B1 但不含有 CYP11B2 启动子的报告基因构建体的 SF-1 介导的转录激活。通过引入相应的小干扰 RNA 减少内源性 Ubc9 和 PIAS1,显著降低了内源性 CYP17、CYP11A1 和 CYP11B1 mRNA 水平,表明它们通常作为 SF-1 的共激活因子发挥作用。野生型和 SUMO 化失活突变型 Ubc9 和 PIAS1 可以类似地增强 SF-1 介导的 CYP17 基因转录激活,表明 Ubc9 和 PIAS1 的共激活能力不依赖于 SUMO 化活性。染色质免疫沉淀实验表明,SF-1、Ubc9 和 PIAS1 在体内染色质背景下被募集到一个内源性 CYP17 基因启动子上。免疫组织化学和 Western blot 分析显示,SF-1、Ubc9 和 PIAS1 表达于人肾上腺皮质的细胞核中。在产生皮质醇的腺瘤中,SF-1 和 Ubc9 的表达模式明显增加,而 PIAS1 的表达则低于相邻的正常肾上腺。这些结果表明,Ubc9 和 PIAS1 在肾上腺皮质类固醇生成中的作用不仅是作为 SF-1 的 SUMO 酶共激活因子,而且在人类产生皮质醇的腺瘤中可能具有潜在的病理生理作用。